XYLOCAINE 1.5% W/ DEXTROSE 7.5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xylocaine 1.5% W/ Dextrose 7.5%, and when can generic versions of Xylocaine 1.5% W/ Dextrose 7.5% launch?
Xylocaine 1.5% W/ Dextrose 7.5% is a drug marketed by Fresenius Kabi Usa and is included in one NDA.
The generic ingredient in XYLOCAINE 1.5% W/ DEXTROSE 7.5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xylocaine 1.5% W/ Dextrose 7.5%
A generic version of XYLOCAINE 1.5% W/ DEXTROSE 7.5% was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for XYLOCAINE 1.5% W/ DEXTROSE 7.5%?
- What are the global sales for XYLOCAINE 1.5% W/ DEXTROSE 7.5%?
- What is Average Wholesale Price for XYLOCAINE 1.5% W/ DEXTROSE 7.5%?
Summary for XYLOCAINE 1.5% W/ DEXTROSE 7.5%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 165 |
| DailyMed Link: | XYLOCAINE 1.5% W/ DEXTROSE 7.5% at DailyMed |
Recent Clinical Trials for XYLOCAINE 1.5% W/ DEXTROSE 7.5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| PAEC General Hospital, Islamabad | PHASE2 |
| Krankenhaus Barmherzige Schwestern Linz | PHASE4 |
| CHU de Reims | N/A |
US Patents and Regulatory Information for XYLOCAINE 1.5% W/ DEXTROSE 7.5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | XYLOCAINE 1.5% W/ DEXTROSE 7.5% | lidocaine hydrochloride | INJECTABLE;SPINAL | 016297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
